Latest Breaking News On - Oncology global development head - Page 1 : comparemela.com

/PRNewswire/ Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug.

Region flamandeUnited statesIsrael generalHeinz josef lenzScott kopetzAdam schayowitzRicha kumariEli lillyJames levineChristoph reinhardKiki patelFairooz kabbinavarJosep taberneroCellphenomics gmbEric van cutsemVan cutsem